{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:35:08Z","timestamp":1787495708962,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Abdul Aziz City for Science and Technology (KACST), National Plan for Science and Technology and Innovation","award":["08-MED 510-02"],"award-info":[{"award-number":["08-MED 510-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06530-1","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:04:15Z","timestamp":1769781855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma clusterin levels in autism spectrum disorder: bridging biomarkers to social and cognitive dysfunctions"],"prefix":"10.1186","volume":"26","author":[{"given":"Nadra Elyass","family":"Elamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durria Ahmed","family":"Abdulmaged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost Muhammad","family":"Halepoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Yousif","family":"Al-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"6530_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5\u2122","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5\u2122. 5th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013.","edition":"5th ed"},{"issue":"1","key":"6530_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41398-023-02374-w","volume":"13","author":"V Khachadourian","year":"2023","unstructured":"Khachadourian V, Mahjani B, Sandin S, Kolevzon A, Buxbaum JD, Reichenberg A, Janecka M. Comorbidities in autism spectrum disorder and their etiologies. Transl Psychiatry. 2023;13(1):71.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"6530_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06392-w","volume":"24","author":"K Salenius","year":"2024","unstructured":"Salenius K, V\u00e4lj\u00e4 N, Thusberg S, Iris F, Ladd-Acosta C, Roos C, et al. Exploring autism spectrum disorder and co-occurring trait associations to elucidate multivariate genetic mechanisms and insights. BMC Psychiatry. 2024;24(1):934.","journal-title":"BMC Psychiatry"},{"issue":"11","key":"6530_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7011a1","volume":"70","author":"MJ Maenner","year":"2021","unstructured":"Maenner MJ, Shaw KA, Bakian AV, Bilder DA, Durkin MS, Esler A, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 Years \u2014 autism and developmental disabilities monitoring Network, 11 Sites, united States, 2018. MMWR Surveill Summ. 2021;70(11):1\u201316.","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"6530_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s10803-023-05923-w","volume":"55","author":"G Kriegel","year":"2025","unstructured":"Kriegel G, Paul S, Leonard KH, Sandor P. Prevalence of autism spectrum disorder (ASD) in inpatient adolescent psychiatric population. J Autism Dev Disord. 2025;55(3):1138\u201345.","journal-title":"J Autism Dev Disord"},{"issue":"7","key":"6530_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","volume":"76","author":"S B\u00f6lte","year":"2019","unstructured":"B\u00f6lte S, Girdler S, Marschik PB. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci. 2019;76(7):1275\u201397.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"6530_CR7","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.3390\/ijms24065487","volume":"24","author":"N Usui","year":"2023","unstructured":"Usui N, Kobayashi H, Shimada S. Neuroinflammation and oxidative stress in the pathogenesis of autism spectrum disorder. Int J Mol Sci. 2023;24(6):5487.","journal-title":"Int J Mol Sci"},{"key":"6530_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","volume":"108","author":"HK Hughes","year":"2023","unstructured":"Hughes HK, Moreno RJ, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain Behav Immun. 2023;108:245\u201354.","journal-title":"Brain Behav Immun"},{"key":"6530_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106520","volume":"197","author":"RE Frye","year":"2024","unstructured":"Frye RE, Rincon N, McCarty PJ, Brister D, Scheck AC, Rossignol DA. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: a systematic review and meta-analysis. Neurobiol Dis. 2024;197:106520.","journal-title":"Neurobiol Dis"},{"key":"6530_CR10","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.3390\/jcm13226695","volume":"13","author":"A El-Ansary","year":"2024","unstructured":"El-Ansary A, Alhakbany M, Alfawaz HA, Al-Ayadhi LY. Indian hedgehog (IHh) protein and COX-2 as biomarkers to define the mechanism of epilepsy and gastrointestinal problems as comorbid medical illnesses in autism spectrum disorder: combining roc curves to improve diagnostic values. J Clin Med. 2024;13:6695.","journal-title":"J Clin Med"},{"issue":"12","key":"6530_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103849","volume":"30","author":"WM Al-Bishri","year":"2023","unstructured":"Al-Bishri WM. Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: novel biomarker sources for clinical diagnosis. Saudi J Biol Sci. 2023;30(12):103849.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"6530_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.9758\/cpn.23.1153","volume":"22","author":"F \u00d6z","year":"2024","unstructured":"\u00d6z F, Kaya \u0130, Tan\u0131r Y, K\u00fc\u00e7\u00fckgergin C, Ayd\u0131n AF. Comparison of serum neurofilament light chain and tau protein levels in cases with autism spectrum disorder and their healthy siblings and healthy controls. Clin Psychopharmacol Neurosci. 2024;22(3):502\u201311.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"5","key":"6530_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40291-022-00600-7","volume":"26","author":"AR Jensen","year":"2022","unstructured":"Jensen AR, Lane AL, Werner BA, McLees SE, Fletcher TS, Frye RE. Modern biomarkers for autism spectrum disorder: future directions. Mol Diagn Ther. 2022;26(5):483\u201395.","journal-title":"Mol Diagn Ther"},{"key":"6530_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Carlomagno Y, Sens JP, Kang SS, Jensen TD, Kurti A, et al. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol Commun. 2020;8:210.","journal-title":"Acta Neuropathol Commun"},{"key":"6530_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111174","volume":"134","author":"C Rodr\u00edguez-Rivera","year":"2021","unstructured":"Rodr\u00edguez-Rivera C, Garcia MM, Molina-\u00c1lvarez M, Gonz\u00e1lez-Mart\u00edn C, Goicoechea C. Clusterin: always protecting. Synthesis, function and potential issues. Biomed Pharmacother. 2021;134:111174.","journal-title":"Biomed Pharmacother"},{"key":"6530_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7657876","volume":"2022","author":"E Janiszewska","year":"2022","unstructured":"Janiszewska E, Kmieciak A, Kacperczyk M, Witkowska A, Kratz EM. The influence of clusterin glycosylation variability on selected pathophysiological processes in the human body. Oxid Med Cell Longev. 2022;2022:7657876.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"6530_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10555-024-10173-y","volume":"43","author":"S Hlavca","year":"2024","unstructured":"Hlavca S, Chan WH, Engel RM, Abud HE. Clusterin: a marker and mediator of chemoresistance in colorectal cancer. Cancer Metastasis Rev. 2024;43(1):379\u201391.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"6530_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz003","volume":"1","author":"RJ Jackson","year":"2019","unstructured":"Jackson RJ, Rose J, Tulloch J, Henstridge C, Smith C, Spires-Jones TL. Clusterin accumulates in synapses in Alzheimer\u2019s disease and is increased in apolipoprotein E4 carriers. Brain Commun. 2019;1(1):fcz003.","journal-title":"Brain Commun"},{"key":"6530_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","volume":"600","author":"Z De Miguel","year":"2021","unstructured":"De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N, et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature. 2021;600:494\u20139.","journal-title":"Nature"},{"issue":"9","key":"6530_CR20","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1210\/clinem\/dgaa378","volume":"105","author":"J Ha","year":"2020","unstructured":"Ha J, Moon MK, Kim H, Park M, Cho SY, Lee J, et al. Plasma clusterin as a potential link between diabetes and Alzheimer disease. J Clin Endocrinol Metab. 2020;105(9):3058\u201368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6530_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-022-00908-0","volume":"7","author":"CC Liu","year":"2022","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. Apolipoprotein J (clusterin) in Alzheimer\u2019s disease: pathological roles and therapeutic strategies. Signal Transduct Target Ther. 2022;7(1):73.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6530_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-024-00428-7","volume":"13","author":"R Zhao","year":"2024","unstructured":"Zhao R. Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis. Transl Neurodegener. 2024;13(1):36.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"6530_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-021-00426-7","volume":"16","author":"F Chen","year":"2021","unstructured":"Chen F, Swartzlander DB, Ghosh A, Fryer JD, Wang B, Zheng H. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer\u2019s disease neuropathology. Mol Neurodegener. 2021;16:5.","journal-title":"Mol Neurodegener"},{"key":"6530_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10072-018-3259-8","volume":"39","author":"R Zhu","year":"2018","unstructured":"Zhu R, Liu X, He Z. Association between CLU gene rs11136000 polymorphism and alzheimer\u2019s disease: an updated meta-analysis. Neurol Sci. 2018;39:679\u201389.","journal-title":"Neurol Sci"},{"key":"6530_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061481","volume":"20","author":"B Pajak","year":"2019","unstructured":"Pajak B, Kania E, Go\u0142aszewska A, Orzechowski A. Preliminary study on clusterin protein (sCLU) expression in PC-12 cells overexpressing wild-type and mutated (Swedish) APP genes affected by non-steroid isoprenoids and water-soluble cholesterol. Int J Mol Sci. 2019;20:1481.","journal-title":"Int J Mol Sci"},{"key":"6530_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/alz.062741","volume":"18","author":"MT Dauar","year":"2022","unstructured":"Dauar MT, Picard C, Rosa-Neto P, Villeneuve S, Poirier J. Clusterin is associated with Alzheimer\u2019s disease biomarkers and cognitive scores in the pre-symptomatic phase of the disease. Alzheimers Dement. 2022;18:e062741.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6530_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56683-6","volume":"9","author":"S Das Gupta","year":"2019","unstructured":"Das Gupta S, Lipponen A, Paldanius KMA, Puhakka N, Pitk\u00e4nen A. Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury. Sci Rep. 2019;9(1):20208.","journal-title":"Sci Rep"},{"issue":"13\u201314","key":"6530_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.clinbiochem.2012.04.024","volume":"45","author":"AM Nafee","year":"2012","unstructured":"Nafee AM, Pasha HF, Abd El Aal SM, Mostafa NA. Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma. Clin Biochem. 2012;45(13\u201314):1070\u20134.","journal-title":"Clin Biochem"},{"issue":"1\u20133","key":"6530_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.schres.2015.10.002","volume":"169","author":"KM Athanas","year":"2015","unstructured":"Athanas KM, Mauney SL, Woo TW. Increased extracellular clusterin in the prefrontal cortex in schizophrenia. Schizophr Res. 2015;169(1\u20133):381\u20135.","journal-title":"Schizophr Res"},{"issue":"1","key":"6530_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0319-x","volume":"9","author":"JL Hsu","year":"2017","unstructured":"Hsu JL, Lee WJ, Liao YC, Wang SJ, Fuh JL. The clinical significance of plasma clusterin and A\u03b2 in the longitudinal follow-up of patients with Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9(1):91.","journal-title":"Alzheimers Res Ther"},{"key":"6530_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23167-z","volume":"12","author":"EM Foster","year":"2022","unstructured":"Foster EM, Fernandes M, Dangla-Valls A, Hublitz P, Pangalos M, Lovestone S, et al. Glycosylated clusterin species facilitate A\u03b2 toxicity in human neurons. Sci Rep. 2022;12:18639.","journal-title":"Sci Rep"},{"key":"6530_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2019.10.025","volume":"89","author":"CE Shepherd","year":"2020","unstructured":"Shepherd CE, Affleck AJ, Bahar AY, Carew-Jones F, Halliday GM. Intracellular and secreted forms of clusterin are elevated early in Alzheimer\u2019s disease and associate with both A\u03b2 and tau pathology. Neurobiol Aging. 2020;89:129\u201331.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"6530_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/tcr-22-1882","volume":"12","author":"P Yang","year":"2023","unstructured":"Yang P, Yang Z, Dong Y, Yang L, Peng S, Yuan L, et al. Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. Transl Cancer Res. 2023;12(1):31\u201345.","journal-title":"Transl Cancer Res"},{"key":"6530_CR34","first-page":"912","volume":"23","author":"P Sultana","year":"2024","unstructured":"Sultana P, Novo J. Clusterin: a double-edged sword in cancer and neurological disorders. EXCLI J. 2024;23:912\u201336.","journal-title":"EXCLI J"},{"issue":"1","key":"6530_CR35","doi-asserted-by":"publisher","first-page":"2294564","DOI":"10.1080\/2162402X.2023.2294564","volume":"3","author":"\u00c1 L\u00f3pez Malizia","year":"2023","unstructured":"L\u00f3pez Malizia \u00c1, Merlotti A, Bonte PE, Sager M, Arribas De Sandoval Y, Goudot C, et al. Clusterin protects mature dendritic cells from reactive oxygen species mediated cell death. Oncoimmunology. 2023;3(1):2294564.","journal-title":"Oncoimmunology"},{"key":"6530_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76875-9","volume":"10","author":"W Udomsinprasert","year":"2020","unstructured":"Udomsinprasert W, Poovorawan Y, Chongsrisawat V, Vejchapipat P, Honsawek S. Decreased circulating clusterin reflects severe liver complications after hepatoportoenterostomy of biliary atresia. Sci Rep. 2020;10:19736.","journal-title":"Sci Rep"},{"key":"6530_CR37","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.1038\/s41598-021-90973-2","volume":"11","author":"T Krop\u00e1\u010dkov\u00e1","year":"2012","unstructured":"Krop\u00e1\u010dkov\u00e1 T, Mann H, R\u016f\u017ei\u010dkov\u00e1 O, \u0160l\u00e9glov\u00e1 O, Vernerov\u00e1 L, Horv\u00e1thov\u00e1 V, et al. Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response. Sci Rep. 2012;11:11525.","journal-title":"Sci Rep"},{"issue":"6","key":"6530_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063438","volume":"25","author":"M\u00c1 Gonz\u00e1lez-Nicol\u00e1s","year":"2024","unstructured":"Gonz\u00e1lez-Nicol\u00e1s M\u00c1, Gonz\u00e1lez-Guerrero C, Goicoechea M, Bosc\u00e1 L, Vali\u00f1o-Rivas L, L\u00e1zaro A. Biomarkers in contrast-induced acute kidney injury: towards a new perspective. Int J Mol Sci. 2024;25(6):3438.","journal-title":"Int J Mol Sci"},{"key":"6530_CR39","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3390\/diagnostics12123010","volume":"12","author":"E Yagmur","year":"2022","unstructured":"Yagmur E, Abu Jhaisha S, Buendgens L, Sapundzhieva N, Brozat JF, Hohlstein P, et al. Clusterin plasma concentrations are decreased in sepsis and inversely correlated with established markers of inflammation. Diagnostics. 2022;12:3010.","journal-title":"Diagnostics"},{"key":"6530_CR40","volume-title":"Childhood autism rating scale (CARS2)","author":"E Schopler","year":"2010","unstructured":"Schopler E, Van Bourgondien ME, Wellman GJ, Love SR. Childhood autism rating scale (CARS2). Los Angeles, CA: Western Psychological Services; 2010."},{"issue":"4","key":"6530_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/A:1025014929212","volume":"33","author":"JN Constantino","year":"2003","unstructured":"Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427\u201333.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"6530_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267.","journal-title":"Signal Transduct Target Ther"},{"key":"6530_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"JM Gregory","year":"2017","unstructured":"Gregory JM, Whiten DR, Brown RA, Barros TP, Kumita JR, Yerbury JJ, et al. Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol Commun. 2017;5:81.","journal-title":"Acta Neuropathol Commun"},{"key":"6530_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, et al. Association of plasma clusterin concentration with severity, pathology, and progression in alzheimer disease. Arch Gen Psychiatry. 2010;67:739\u201348.","journal-title":"Arch Gen Psychiatry"},{"key":"6530_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","volume":"59","author":"M Thambisetty","year":"2012","unstructured":"Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, Guntert A, et al. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. NeuroImage. 2012;59:212\u20137.","journal-title":"NeuroImage"},{"issue":"2","key":"6530_CR46","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"JT Yu","year":"2012","unstructured":"Yu JT, Tan L. The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol Neurobiol. 2012;45(2):314\u201326.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"6530_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050237","volume":"7","author":"E Silajd\u017ei\u0107","year":"2012","unstructured":"Silajd\u017ei\u0107 E, Minthon L, Bj\u00f6rkqvist M, Hansson O. No diagnostic value of plasma clusterin in Alzheimer\u2019s disease. PLoS One. 2012;7(11):e50237.","journal-title":"PLoS One"},{"issue":"3","key":"6530_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S. Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol. 2017;27(3):305\u201313.","journal-title":"Brain Pathol"},{"key":"6530_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.823736","volume":"13","author":"XB Lin","year":"2022","unstructured":"Lin XB, Lim CG, Lee TS. Social deficits or interactional differences? Interrogating perspectives on social functioning in autism. Front Psychiatry. 2022;13:823736.","journal-title":"Front Psychiatry"},{"issue":"1","key":"6530_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01916-2","volume":"29","author":"L Qin","year":"2024","unstructured":"Qin L, Wang H, Ning W, Cui M, Wang Q. New advances in the diagnosis and treatment of autism spectrum disorders. Eur J Med Res. 2024;29(1):322.","journal-title":"Eur J Med Res"},{"issue":"14","key":"6530_CR51","doi-asserted-by":"publisher","first-page":"11710","DOI":"10.3390\/ijms241411710","volume":"24","author":"N Ferencova","year":"2023","unstructured":"Ferencova N, Visnovcova Z, Ondrejka I, Hrtanek I, Bujnakova I, Kovacova V, et al. Peripheral inflammatory markers in autism spectrum disorder and attention Deficit\/Hyperactivity disorder at adolescent age. Int J Mol Sci. 2023;24(14):11710.","journal-title":"Int J Mol Sci"},{"key":"6530_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-05182-3","volume":"24","author":"AS Noori","year":"2024","unstructured":"Noori AS, Rajabi P, Sargolzaei J, Alaghmand A. Correlation of biochemical markers and inflammatory cytokines in autism spectrum disorder (ASD). BMC Pediatr. 2024;24:696.","journal-title":"BMC Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06530-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:58:55Z","timestamp":1772024335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06530-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6530"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06530-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of King Saud University (Approval number: 24\/1706\/IRB on 13 October 2024). An informed consent was obtained from the parents or legal guardians of all participants prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}